Oxidative Stress in the Amygdala Contributes to Neuropathic Pain
- PMID: 29274353
- DOI: 10.1016/j.neuroscience.2017.12.009
Oxidative Stress in the Amygdala Contributes to Neuropathic Pain
Abstract
Earlier studies indicate that the central nucleus of the amygdala (CeA) contributes to neuropathic pain. Here we studied whether amygdaloid administration of antioxidants or antagonists of TRPA1 that is among ion channels activated by oxidative stress attenuates nociceptive or affective pain in experimental neuropathy, and whether this effect involves amygdaloid astrocytes or descending serotonergic pathways acting on the spinal 5-HT1A receptor. The experiments were performed in rats with spared nerve injury (SNI). Drugs were administered through a chronic cannula in the CeA or internal capsule (control site), and an intrathecal catheter. Nociception was assessed using monofilaments and affective pain using conditioned place-aversion. Antioxidants or TRPA1 antagonists in the CeA attenuated both nociceptive and affective pain in SNI animals but not in sham controls or in a control injection site. Drugs influencing astroglia (a gap junction decoupler or a D-amino acid oxidase inhibitor) in the CeA had no effect on SNI rats, whereas local anesthesia of the CeA attenuated nociception. Spinally administered 5-HT1A receptor antagonist at a dose that had no effect alone prevented the antinociceptive effect of amygdaloid TRPA1 blockers. The results suggest that injury-induced amygdaloid oxidative stress that drives TRPA1 promotes neuropathic pain behavior. This pronociceptive effect involves suppression of medullospinal serotonergic feedback-inhibition acting on the spinal 5-HT1A receptor. While the CeA is involved in mediating the nerve injury-induced pronociception, it may not be a critical relay for the recruitment of medullospinal feedback-inhibition.
Keywords: A-967079 (PubChem CID: 60150207); AS-057278 (PubChem CID: 9822); Carbenoxolone (PubChem CID: 24892726); Chembridge-5861528 (PubChem CID: 2873523); Lidocaine (PubChem CID: 3676); Phenyl-N-tert-butylnitrone (PubChem CID: 638877); TEMPOL (PubChem CID: 137994); WAY-100635 (PubChem CID: 5684); amygdala; antioxidant; descending pain modulation; neuropathic pain; spinal 5-HT(1A) receptor; tert-butyl-hydroperoxide (PubChem CID: 6410); transient receptor potential ankyrin 1.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Bidirectional amygdaloid control of neuropathic hypersensitivity mediated by descending serotonergic pathways acting on spinal 5-HT3 and 5-HT1A receptors.Behav Brain Res. 2015 Apr 1;282:14-24. doi: 10.1016/j.bbr.2014.12.052. Epub 2014 Dec 31. Behav Brain Res. 2015. PMID: 25557801
-
Amygdaloid administration of tetrapentylammonium attenuates development of pain and anxiety-like behavior following peripheral nerve injury.Pharmacol Rep. 2019 Feb;71(1):54-60. doi: 10.1016/j.pharep.2018.08.005. Epub 2018 Aug 17. Pharmacol Rep. 2019. PMID: 30465925
-
Regulation of neuropathic pain behavior by amygdaloid TRPC4/C5 channels.Neurosci Lett. 2015 Nov 3;608:12-7. doi: 10.1016/j.neulet.2015.09.033. Epub 2015 Sep 30. Neurosci Lett. 2015. PMID: 26432495
-
TRPA1 Antagonists for Pain Relief.Pharmaceuticals (Basel). 2018 Nov 1;11(4):117. doi: 10.3390/ph11040117. Pharmaceuticals (Basel). 2018. PMID: 30388732 Free PMC article. Review.
-
Minocycline as a promising therapeutic strategy for chronic pain.Pharmacol Res. 2018 Aug;134:305-310. doi: 10.1016/j.phrs.2018.07.002. Epub 2018 Jul 6. Pharmacol Res. 2018. PMID: 30042091 Review.
Cited by
-
Abnormal brain spontaneous neural activity in neuromyelitis optica spectrum disorder with neuropathic pain.Front Neurol. 2024 Jun 12;15:1408759. doi: 10.3389/fneur.2024.1408759. eCollection 2024. Front Neurol. 2024. PMID: 38938780 Free PMC article.
-
The antioxidant N-(2-mercaptopropionyl)-glycine (tiopronin) attenuates expression of neuropathic allodynia and hyperalgesia.Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):603-617. doi: 10.1007/s00210-020-01995-y. Epub 2020 Oct 20. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 33079239
-
Clinical Validation of a Multi-Biomarker Assay for the Evaluation of Chronic Pain Patients in a Cross-Sectional, Observational Study.Pain Ther. 2020 Dec;9(2):511-529. doi: 10.1007/s40122-020-00175-3. Epub 2020 Jun 3. Pain Ther. 2020. PMID: 32495188 Free PMC article.
-
Manganese-enhanced MRI reveals changes within brain anxiety and aversion circuitry in rats with chronic neuropathic pain- and anxiety-like behaviors.Neuroimage. 2020 Dec;223:117343. doi: 10.1016/j.neuroimage.2020.117343. Epub 2020 Sep 6. Neuroimage. 2020. PMID: 32898676 Free PMC article.
-
Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain?Int J Mol Sci. 2019 Jun 14;20(12):2906. doi: 10.3390/ijms20122906. Int J Mol Sci. 2019. PMID: 31197115 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous